71326 Federal Register / Vol. 70, No. 227 / Monday, November 28, 2005 / Notices 

Dated: November 18, 2005. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–23342 Filed 11–25–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Kidney, 

Nutrition, Obesity and Diabetes (KNOD) 

Member Conflicts. 

Date: November 28, 2005. 

Time: 11 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Mary Ann Guadagno, 

PhD., Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3170, MSC 7770, Bethesda, MD 20892, 

(301) 451–8011, guadagma@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Endothelial 

Dysfunction Special Emphasis Panel. 

Date: November 30, 2005. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Lawrence E. Boerboom, 

PhD., Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 5156, MSC 7814, Bethesda, MD 20892, 

(301) 435–8367, boerboom@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Energy and 

Glucose Homeostasis. 

Date: December 2, 2005. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Ann A. Jerkins, PhD., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6154, 

MSC 7892, Bethesda, MD 20892, 301–435–

4514, jerkinsa@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Collaborative Projects with NCBCs. 

Date: December 4–5, 2005. 

Time: 7:30 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Malgorzata Klosek, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4188, 

MSC 7849, Bethesda, MD 20892, (301) 435–

2211, klosekm@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Center for Scientific Review Special 

Emphasis Panel, Quiescence Program Project. 

Date: December 6, 2005. 

Time: 2:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Charles R. Dearolf, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5142, 

MSC 7840, Bethesda, MD 20892, 301–435–

1024, dearolfc@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS). 

Dated: November 16, 2005. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–23349 Filed 11–25–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: Call Monitoring of National 

Suicide Prevention Lifeline Form—

NEW 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA), Center for Mental Health 

Services has funded a National Suicide 

Prevention Lifeline Network, consisting 

of a single toll-free telephone number 

that routes calls from anywhere in the 

United States to a network of local crisis 

centers. In turn, the local centers link 

callers to local emergency, mental 

health, and social service resources. 

To ensure quality, the vast majority of 

crisis centers conduct on-site 

monitoring of selected calls by 

supervisors or trainers using 

unobtrusive listening devices. To 

monitor the quality of calls and to 

inform the development of training for 

networked crisis centers, the National 

Suicide Prevention Lifeline propose to 

remotely monitor calls routed to seven 

crisis centers during the shifts of 

consenting staff. The procedure will be 

anonymous, in that neither staff nor 

callers will be identified on the Call 

Monitoring Form. The monitor, a 

trained crisis worker, will code the type 

of problem presented by the caller, the 

elements of a suicide risk assessment 

that are completed by the crisis worker, 

as well as what action plan is developed 

with and/or what referral(s) are 

provided to the caller. No centers will 

be identified in reports. 

During the shifts of consenting crisis 

staff, a recording will inform callers that 

some calls may be monitored for quality 

assurance purposes. Previous 

comparisons of matched centers that did 

and did not play the recording found no 

difference in hang-up rates before the 

calls were answered or within the first 

15 seconds of the calls. 

The seven centers to be monitored 

will be selected based on the geographic 

region(s) they serve. Once a center has